409 related articles for article (PubMed ID: 30888254)
21. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
23. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic.
Shahlapour M; Singh S; Christine PJ; Laks J; Evans J; Farrell NM; Khan GK; Taylor JL; Rozansky H
J Addict Med; 2024 May-Jun 01; 18(3):345-347. PubMed ID: 38329815
[TBL] [Abstract][Full Text] [Related]
24. Naltrexone shortened opioid detoxification with buprenorphine.
Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
[TBL] [Abstract][Full Text] [Related]
25. CE: Acute Pain Management for People with Opioid Use Disorder.
Broglio K; Matzo M
Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
[TBL] [Abstract][Full Text] [Related]
27. Detoxification and treating opioid dependence.
de Jong CJ
JAMA; 2006 Feb; 295(8):887; author reply 887-8. PubMed ID: 16493098
[No Abstract] [Full Text] [Related]
28. Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.
Szczesniak LM; Calleo VJ; Sullivan RW
Harm Reduct J; 2020 Oct; 17(1):71. PubMed ID: 33028340
[TBL] [Abstract][Full Text] [Related]
29. Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.
Srivastava A; Kahan M; Njoroge I; Sommer LZ
Can Fam Physician; 2019 May; 65(5):e214-e220. PubMed ID: 31088887
[TBL] [Abstract][Full Text] [Related]
30. Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.
De Aquino JP; Fairgrieve C; Klaire S; Garcia-Vassallo G
J Addict Med; 2020; 14(5):e271-e273. PubMed ID: 32011408
[TBL] [Abstract][Full Text] [Related]
31. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
32. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
Shulman M; Wai JM; Nunes EV
CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
[TBL] [Abstract][Full Text] [Related]
33. Heroin anticraving medications: a systematic review.
Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
[TBL] [Abstract][Full Text] [Related]
34. Buprenorphine for the management of opioid withdrawal.
Gowing L; Ali R; White J
Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553
[TBL] [Abstract][Full Text] [Related]
35. Methods of detoxification and their role in treating patients with opioid dependence.
O'Connor PG
JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388
[No Abstract] [Full Text] [Related]
36. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
37. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
Bishop B; Gilmour J; Deering D
Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
[TBL] [Abstract][Full Text] [Related]
38. Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
[No Abstract] [Full Text] [Related]
39. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine for the management of opioid withdrawal.
Gowing L; Ali R; White JM
Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
